Insider Transactions in Q1 2023 at Oak Street Health, Inc. (OSH)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
450,000
-5.47%
|
$17,100,000
$38.69 P/Share
|
|
Mar 31
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
450,000
+5.19%
|
$9,450,000
$21.0 P/Share
|
|
Mar 24
2023
|
Michael T Pykosz Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,282,000
-16.86%
|
-
|
|
Mar 21
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.27%
|
$1,750,000
$35.73 P/Share
|
|
Mar 21
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.26%
|
$1,050,000
$21.0 P/Share
|
|
Mar 20
2023
|
Robert Guenthner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,699
+8.83%
|
-
|
|
Mar 20
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,611
+0.14%
|
-
|
|
Mar 20
2023
|
Timothy M Cook Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
92,592
+5.96%
|
-
|
|
Mar 20
2023
|
Brian Clem Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
101,010
+15.06%
|
-
|
|
Mar 20
2023
|
Griffin Myers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,611
+39.73%
|
-
|
|
Mar 20
2023
|
Michael T Pykosz Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,408
+2.52%
|
-
|
|
Mar 17
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
37,913
-0.97%
|
$1,326,955
$35.63 P/Share
|
|
Mar 17
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
37,913
+0.96%
|
$796,173
$21.0 P/Share
|
|
Mar 16
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
79,858
-2.02%
|
$2,795,030
$35.62 P/Share
|
|
Mar 16
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,858
+1.98%
|
$1,677,018
$21.0 P/Share
|
|
Mar 15
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
1,831
-0.05%
|
$64,085
$35.6 P/Share
|
|
Mar 15
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
1,831
-0.05%
|
$38,451
$21.0 P/Share
|
|
Mar 13
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,296
+0.29%
|
-
|
|
Mar 13
2023
|
Griffin Myers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,852
+49.58%
|
-
|
|
Mar 13
2023
|
Timothy M Cook Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,458
+1.26%
|
-
|
|
Mar 13
2023
|
Michael T Pykosz Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,605
+0.35%
|
-
|
|
Mar 13
2023
|
Robert Guenthner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,981
+2.62%
|
-
|
|
Mar 09
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,250
-1.87%
|
$288,750
$35.43 P/Share
|
|
Mar 07
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.29%
|
$1,750,000
$35.54 P/Share
|
|
Mar 07
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.28%
|
$1,050,000
$21.0 P/Share
|
|
Feb 23
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
7,728
-0.2%
|
$270,480
$35.48 P/Share
|
|
Feb 23
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,768
-1.2%
|
$376,880
$35.47 P/Share
|
|
Feb 23
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,107
-0.38%
|
$178,745
$35.48 P/Share
|
|
Feb 22
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
122,985
-3.08%
|
$4,304,475
$35.61 P/Share
|
|
Feb 22
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
122,985
+2.98%
|
$2,582,685
$21.0 P/Share
|
|
Feb 21
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.27%
|
$1,750,000
$35.32 P/Share
|
|
Feb 21
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.26%
|
$1,050,000
$21.0 P/Share
|
|
Feb 10
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
7,413
-0.19%
|
$259,455
$35.6 P/Share
|
|
Feb 10
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,413
+0.19%
|
$155,673
$21.0 P/Share
|
|
Feb 09
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,250
-1.79%
|
$288,750
$35.26 P/Share
|
|
Feb 07
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
400,000
-9.36%
|
$13,600,000
$34.07 P/Share
|
|
Feb 07
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400,000
+8.56%
|
$8,400,000
$21.0 P/Share
|
|
Feb 02
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,480
-0.11%
|
$41,440
$28.49 P/Share
|
|
Feb 02
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
592
-0.13%
|
$16,576
$28.85 P/Share
|
|
Jan 26
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,250
-0.88%
|
$231,000
$28.52 P/Share
|
|
Jan 13
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,809
-4.25%
|
$624,270
$30.15 P/Share
|
|
Jan 12
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,601
-1.33%
|
$198,030
$30.02 P/Share
|
|
Jan 11
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
32,590
-6.16%
|
$977,700
$30.11 P/Share
|
|
Jan 10
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.29%
|
$1,450,000
$29.74 P/Share
|
|
Jan 10
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.27%
|
$1,050,000
$21.0 P/Share
|
|
Jan 10
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
17,569
-1.61%
|
$509,501
$29.22 P/Share
|
|
Jan 03
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.45%
|
$115,000
$23.1 P/Share
|